Yahoo Finance

Eterna Therapeutics Appoints Matt Angel, Ph.D. as Chief Executive Officer and President

CAMBRIDGE, Mass., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”), a biopharmaceutical company using advanced cell engineering technology to ...
Morningstar

Eterna Growth Partners Completes Spinout of the Technology Opportunities Strategy from Charlesbank

Charlesbank Technology Opportunities team and funds finalize legal separation and rebrand as Eterna Growth Partners. Newly independent firm will continue to manage its two private equity funds with $2 ...
Yahoo Finance

Eterna Therapeutics and Factor Bioscience Announce Exclusive License and Collaboration Agreement to Accelerate Cell Therapy Development for Oncology, Autoimmune, and Rare Diseases

CAMBRIDGE, Mass., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”) and Factor Bioscience Limited (“Factor”) today announced an exclusive license ...
Nasdaq

Eterna Therapeutics Appoints Dr. Elena Ratner to Board of Directors to Enhance Focus on Ovarian Cancer Research

Eterna Therapeutics has appointed Dr. Elena Ratner to its Board of Directors to lead the company's initiatives against ovarian cancer. Dr. Ratner, an expert in obstetrics and gynecology, aims to ...
MarketWatch

CORRECTING AND REPLACING: Eterna Growth Partners Completes Spinout of the Technology Opportunities Strategy from Charlesbank

The MarketWatch News Department was not involved in the creation of this content. -- Charlesbank Technology Opportunities team and funds finalize legal separation and rebrand as Eterna Growth Partners ...